Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de M. Behrens
Age : 68
Public asset : 13,724,263 USD
Country of residence : Unknown
Linked companies : Sarepta Therapeutics, Inc. - MiMedx Group, Inc. - IGM Biosciences, Inc.

Biography of M. Behrens 
Founder of Kew, Inc. and The Coalition for 21st Century Medicine, M. Kathleen Behrens Wilsey presently occupies the position of Chairman for Sarepta Therapeutics, Inc. and Chairman for MiMedx Group, Inc. Dr. Wilsey is also on the board of IGM Biosciences, Inc. Dr. Wilsey previously was Chairman & President for National Venture Capital Association, President & Chief Executive Officer of Kew, Inc., Managing Director at RS Investment Management Co. LLC, Managing Director & General Partner at Robertson Stephens & Co. and Director-Science, Technology & Economic Policy at The National Research Council. M. Kathleen Behrens Wilsey received an undergraduate degree and a doctorate from the University of California, Davis.


Current positions of M. Behrens 
Holdings of M. Behrens 
M. Behrens : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/09ELON MUSK : Musk tweet on Japan doomed by low birthrate provokes anger - but not just at him
RE
More news


© 2022 People and Ownership :   
M. Behrens : Connections 


Latest news about M. Behrens 
2021TRANSCRIPT : Sarepta Therapeutics, Inc. - Shareholder/Analyst Call
CI
2020TRANSCRIPT : Sarepta Therapeutics, Inc. - Shareholder/Analyst Call
CI
2019Declaration of Voting Results by MiMedx Group
CI
2019MiMedx Group, Inc. Announces Board and Committee Changes
CI
2019MiMedx Group Highlights Skills and Experience of Director Nominees
CI
2019MiMedx Group Nominates Additional Nominees to its Board
CI
2019MiMedx Group Provides Information to Shareholders
CI
More news